Stock Price
2.17
Daily Change
-0.18 -7.66%
Monthly
-3.98%
Yearly
69.53%
Q2 Forecast
2.06

Galectin Therapeutics reported $-12.37M in Pre-Tax Profit for its fiscal quarter ending in June of 2024.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Galectin Therapeutics USD -12.37M 880K Jun/2024
Gilead Sciences USD 2.08B 1.56B Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Incyte USD 343.6M 46.34M Mar/2026
Merck USD 3.42B 3.32B Dec/2025